Philogen Adds to Treasury Stock with Ongoing Share Buyback on Euronext Milan

Philogen SpA ( (IT:PHIL) ) has issued an update.

Philogen has reported fresh progress in its ongoing share buyback programme, acquiring 1,503 shares on Euronext Milan between 23 and 27 February 2026 at an average price of €20.9081, for a total outlay of €31,424.85. Since the programme’s launch, the company has repurchased 55,876 shares for about €1.23 million and now holds 349,826 treasury shares, equal to 0.8614% of its share capital, signalling continued balance-sheet strength and capital management discipline.

The latest tranche of purchases modestly increases Philogen’s treasury stock while maintaining a relatively small overall percentage of the share capital tied up in buybacks. For investors, the continued execution of the programme under EU regulatory rules underscores management’s confidence in the company’s valuation and provides incremental support to the share price without materially altering the free float at this stage.

The most recent analyst rating on (IT:PHIL) stock is a Buy with a EUR24.50 price target. To see the full list of analyst forecasts on Philogen SpA stock, see the IT:PHIL Stock Forecast page.

More about Philogen SpA

Philogen is an Italian-Swiss biotechnology group focused on discovering and developing targeted anti-cancer drugs for diseases with high mortality rates. Its core technology uses tumour-targeting ligands, including human monoclonal antibodies and small organic molecules, to deliver potent therapeutics directly to tumour tissue while sparing healthy cells, with potential applications also in chronic inflammatory diseases.

YTD Price Performance: -9.87%

Average Trading Volume: 21,398

Technical Sentiment Signal: Hold

Current Market Cap: €614.1M

For an in-depth examination of PHIL stock, go to TipRanks’ Overview page.